1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Biological Drug CDMO Market Size (2020-2031) 2.1.2 Biological Drug CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) 2.1.3 World Current & Future Analysis for Biological Drug CDMO by Country/Region (2020, 2024 & 2031) 2.2 Biological Drug CDMO Segment by Type 2.2.1 Cell and Gene Therapies 2.2.2 Antibodies 2.2.3 Vaccines 2.2.4 Other 2.3 Biological Drug CDMO Market Size by Type 2.3.1 Biological Drug CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031) 2.3.2 Global Biological Drug CDMO Market Size Market Share by Type (2020-2025) 2.4 Biological Drug CDMO Segment by Application 2.4.1 SMBs 2.4.2 Large Companies 2.5 Biological Drug CDMO Market Size by Application 2.5.1 Biological Drug CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) 2.5.2 Global Biological Drug CDMO Market Size Market Share by Application (2020-2025) 3 Biological Drug CDMO Market Size by Player 3.1 Biological Drug CDMO Market Size Market Share by Player 3.1.1 Global Biological Drug CDMO Revenue by Player (2020-2025) 3.1.2 Global Biological Drug CDMO Revenue Market Share by Player (2020-2025) 3.2 Global Biological Drug CDMO Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Biological Drug CDMO by Region 4.1 Biological Drug CDMO Market Size by Region (2020-2025) 4.2 Global Biological Drug CDMO Annual Revenue by Country/Region (2020-2025) 4.3 Americas Biological Drug CDMO Market Size Growth (2020-2025) 4.4 APAC Biological Drug CDMO Market Size Growth (2020-2025) 4.5 Europe Biological Drug CDMO Market Size Growth (2020-2025) 4.6 Middle East & Africa Biological Drug CDMO Market Size Growth (2020-2025) 5 Americas 5.1 Americas Biological Drug CDMO Market Size by Country (2020-2025) 5.2 Americas Biological Drug CDMO Market Size by Type (2020-2025) 5.3 Americas Biological Drug CDMO Market Size by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Biological Drug CDMO Market Size by Region (2020-2025) 6.2 APAC Biological Drug CDMO Market Size by Type (2020-2025) 6.3 APAC Biological Drug CDMO Market Size by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Biological Drug CDMO Market Size by Country (2020-2025) 7.2 Europe Biological Drug CDMO Market Size by Type (2020-2025) 7.3 Europe Biological Drug CDMO Market Size by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Biological Drug CDMO by Region (2020-2025) 8.2 Middle East & Africa Biological Drug CDMO Market Size by Type (2020-2025) 8.3 Middle East & Africa Biological Drug CDMO Market Size by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Biological Drug CDMO Market Forecast 10.1 Global Biological Drug CDMO Forecast by Region (2026-2031) 10.1.1 Global Biological Drug CDMO Forecast by Region (2026-2031) 10.1.2 Americas Biological Drug CDMO Forecast 10.1.3 APAC Biological Drug CDMO Forecast 10.1.4 Europe Biological Drug CDMO Forecast 10.1.5 Middle East & Africa Biological Drug CDMO Forecast 10.2 Americas Biological Drug CDMO Forecast by Country (2026-2031) 10.2.1 United States Market Biological Drug CDMO Forecast 10.2.2 Canada Market Biological Drug CDMO Forecast 10.2.3 Mexico Market Biological Drug CDMO Forecast 10.2.4 Brazil Market Biological Drug CDMO Forecast 10.3 APAC Biological Drug CDMO Forecast by Region (2026-2031) 10.3.1 China Biological Drug CDMO Market Forecast 10.3.2 Japan Market Biological Drug CDMO Forecast 10.3.3 Korea Market Biological Drug CDMO Forecast 10.3.4 Southeast Asia Market Biological Drug CDMO Forecast 10.3.5 India Market Biological Drug CDMO Forecast 10.3.6 Australia Market Biological Drug CDMO Forecast 10.4 Europe Biological Drug CDMO Forecast by Country (2026-2031) 10.4.1 Germany Market Biological Drug CDMO Forecast 10.4.2 France Market Biological Drug CDMO Forecast 10.4.3 UK Market Biological Drug CDMO Forecast 10.4.4 Italy Market Biological Drug CDMO Forecast 10.4.5 Russia Market Biological Drug CDMO Forecast 10.5 Middle East & Africa Biological Drug CDMO Forecast by Region (2026-2031) 10.5.1 Egypt Market Biological Drug CDMO Forecast 10.5.2 South Africa Market Biological Drug CDMO Forecast 10.5.3 Israel Market Biological Drug CDMO Forecast 10.5.4 Turkey Market Biological Drug CDMO Forecast 10.6 Global Biological Drug CDMO Forecast by Type (2026-2031) 10.7 Global Biological Drug CDMO Forecast by Application (2026-2031) 10.7.1 GCC Countries Market Biological Drug CDMO Forecast 11 Key Players Analysis 11.1 Lonza 11.1.1 Lonza Company Information 11.1.2 Lonza Biological Drug CDMO Product Offered 11.1.3 Lonza Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.1.4 Lonza Main Business Overview 11.1.5 Lonza Latest Developments 11.2 Catalent 11.2.1 Catalent Company Information 11.2.2 Catalent Biological Drug CDMO Product Offered 11.2.3 Catalent Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.2.4 Catalent Main Business Overview 11.2.5 Catalent Latest Developments 11.3 Samsung Biologics 11.3.1 Samsung Biologics Company Information 11.3.2 Samsung Biologics Biological Drug CDMO Product Offered 11.3.3 Samsung Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.3.4 Samsung Biologics Main Business Overview 11.3.5 Samsung Biologics Latest Developments 11.4 FUJIFILM Diosynth Biotechnologies 11.4.1 FUJIFILM Diosynth Biotechnologies Company Information 11.4.2 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product Offered 11.4.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview 11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments 11.5 Boehringer Ingelheim 11.5.1 Boehringer Ingelheim Company Information 11.5.2 Boehringer Ingelheim Biological Drug CDMO Product Offered 11.5.3 Boehringer Ingelheim Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.5.4 Boehringer Ingelheim Main Business Overview 11.5.5 Boehringer Ingelheim Latest Developments 11.6 WuXi Biologics 11.6.1 WuXi Biologics Company Information 11.6.2 WuXi Biologics Biological Drug CDMO Product Offered 11.6.3 WuXi Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.6.4 WuXi Biologics Main Business Overview 11.6.5 WuXi Biologics Latest Developments 11.7 Recipharm 11.7.1 Recipharm Company Information 11.7.2 Recipharm Biological Drug CDMO Product Offered 11.7.3 Recipharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.7.4 Recipharm Main Business Overview 11.7.5 Recipharm Latest Developments 11.8 Thermo Fisher Scientific 11.8.1 Thermo Fisher Scientific Company Information 11.8.2 Thermo Fisher Scientific Biological Drug CDMO Product Offered 11.8.3 Thermo Fisher Scientific Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.8.4 Thermo Fisher Scientific Main Business Overview 11.8.5 Thermo Fisher Scientific Latest Developments 11.9 AGC Biologics 11.9.1 AGC Biologics Company Information 11.9.2 AGC Biologics Biological Drug CDMO Product Offered 11.9.3 AGC Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.9.4 AGC Biologics Main Business Overview 11.9.5 AGC Biologics Latest Developments 11.10 Rentschler Biopharma 11.10.1 Rentschler Biopharma Company Information 11.10.2 Rentschler Biopharma Biological Drug CDMO Product Offered 11.10.3 Rentschler Biopharma Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.10.4 Rentschler Biopharma Main Business Overview 11.10.5 Rentschler Biopharma Latest Developments 11.11 KBI Biopharma 11.11.1 KBI Biopharma Company Information 11.11.2 KBI Biopharma Biological Drug CDMO Product Offered 11.11.3 KBI Biopharma Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.11.4 KBI Biopharma Main Business Overview 11.11.5 KBI Biopharma Latest Developments 11.12 Siegfried 11.12.1 Siegfried Company Information 11.12.2 Siegfried Biological Drug CDMO Product Offered 11.12.3 Siegfried Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.12.4 Siegfried Main Business Overview 11.12.5 Siegfried Latest Developments 11.13 Aenova Group 11.13.1 Aenova Group Company Information 11.13.2 Aenova Group Biological Drug CDMO Product Offered 11.13.3 Aenova Group Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.13.4 Aenova Group Main Business Overview 11.13.5 Aenova Group Latest Developments 11.14 GenScript 11.14.1 GenScript Company Information 11.14.2 GenScript Biological Drug CDMO Product Offered 11.14.3 GenScript Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.14.4 GenScript Main Business Overview 11.14.5 GenScript Latest Developments 11.15 ProBioGen 11.15.1 ProBioGen Company Information 11.15.2 ProBioGen Biological Drug CDMO Product Offered 11.15.3 ProBioGen Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.15.4 ProBioGen Main Business Overview 11.15.5 ProBioGen Latest Developments 11.16 Northway Biotech 11.16.1 Northway Biotech Company Information 11.16.2 Northway Biotech Biological Drug CDMO Product Offered 11.16.3 Northway Biotech Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.16.4 Northway Biotech Main Business Overview 11.16.5 Northway Biotech Latest Developments 11.17 3P Biopharmaceuticals 11.17.1 3P Biopharmaceuticals Company Information 11.17.2 3P Biopharmaceuticals Biological Drug CDMO Product Offered 11.17.3 3P Biopharmaceuticals Biological Drug CDMO Revenue, Gross Margin and Market Share (2020-2025) 11.17.4 3P Biopharmaceuticals Main Business Overview 11.17.5 3P Biopharmaceuticals Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Biological Drug CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions) Table 2. Biological Drug CDMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Cell and Gene Therapies Table 4. Major Players of Antibodies Table 5. Major Players of Vaccines Table 6. Major Players of Other Table 7. Biological Drug CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions) Table 8. Global Biological Drug CDMO Market Size by Type (2020-2025) & ($ millions) Table 9. Global Biological Drug CDMO Market Size Market Share by Type (2020-2025) Table 10. Biological Drug CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions) Table 11. Global Biological Drug CDMO Market Size by Application (2020-2025) & ($ millions) Table 12. Global Biological Drug CDMO Market Size Market Share by Application (2020-2025) Table 13. Global Biological Drug CDMO Revenue by Player (2020-2025) & ($ millions) Table 14. Global Biological Drug CDMO Revenue Market Share by Player (2020-2025) Table 15. Biological Drug CDMO Key Players Head office and Products Offered Table 16. Biological Drug CDMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Biological Drug CDMO Market Size by Region (2020-2025) & ($ millions) Table 20. Global Biological Drug CDMO Market Size Market Share by Region (2020-2025) Table 21. Global Biological Drug CDMO Revenue by Country/Region (2020-2025) & ($ millions) Table 22. Global Biological Drug CDMO Revenue Market Share by Country/Region (2020-2025) Table 23. Americas Biological Drug CDMO Market Size by Country (2020-2025) & ($ millions) Table 24. Americas Biological Drug CDMO Market Size Market Share by Country (2020-2025) Table 25. Americas Biological Drug CDMO Market Size by Type (2020-2025) & ($ millions) Table 26. Americas Biological Drug CDMO Market Size Market Share by Type (2020-2025) Table 27. Americas Biological Drug CDMO Market Size by Application (2020-2025) & ($ millions) Table 28. Americas Biological Drug CDMO Market Size Market Share by Application (2020-2025) Table 29. APAC Biological Drug CDMO Market Size by Region (2020-2025) & ($ millions) Table 30. APAC Biological Drug CDMO Market Size Market Share by Region (2020-2025) Table 31. APAC Biological Drug CDMO Market Size by Type (2020-2025) & ($ millions) Table 32. APAC Biological Drug CDMO Market Size by Application (2020-2025) & ($ millions) Table 33. Europe Biological Drug CDMO Market Size by Country (2020-2025) & ($ millions) Table 34. Europe Biological Drug CDMO Market Size Market Share by Country (2020-2025) Table 35. Europe Biological Drug CDMO Market Size by Type (2020-2025) & ($ millions) Table 36. Europe Biological Drug CDMO Market Size by Application (2020-2025) & ($ millions) Table 37. Middle East & Africa Biological Drug CDMO Market Size by Region (2020-2025) & ($ millions) Table 38. Middle East & Africa Biological Drug CDMO Market Size by Type (2020-2025) & ($ millions) Table 39. Middle East & Africa Biological Drug CDMO Market Size by Application (2020-2025) & ($ millions) Table 40. Key Market Drivers & Growth Opportunities of Biological Drug CDMO Table 41. Key Market Challenges & Risks of Biological Drug CDMO Table 42. Key Industry Trends of Biological Drug CDMO Table 43. Global Biological Drug CDMO Market Size Forecast by Region (2026-2031) & ($ millions) Table 44. Global Biological Drug CDMO Market Size Market Share Forecast by Region (2026-2031) Table 45. Global Biological Drug CDMO Market Size Forecast by Type (2026-2031) & ($ millions) Table 46. Global Biological Drug CDMO Market Size Forecast by Application (2026-2031) & ($ millions) Table 47. Lonza Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 48. Lonza Biological Drug CDMO Product Offered Table 49. Lonza Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 50. Lonza Main Business Table 51. Lonza Latest Developments Table 52. Catalent Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 53. Catalent Biological Drug CDMO Product Offered Table 54. Catalent Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 55. Catalent Main Business Table 56. Catalent Latest Developments Table 57. Samsung Biologics Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 58. Samsung Biologics Biological Drug CDMO Product Offered Table 59. Samsung Biologics Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 60. Samsung Biologics Main Business Table 61. Samsung Biologics Latest Developments Table 62. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 63. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product Offered Table 64. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 65. FUJIFILM Diosynth Biotechnologies Main Business Table 66. FUJIFILM Diosynth Biotechnologies Latest Developments Table 67. Boehringer Ingelheim Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 68. Boehringer Ingelheim Biological Drug CDMO Product Offered Table 69. Boehringer Ingelheim Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 70. Boehringer Ingelheim Main Business Table 71. Boehringer Ingelheim Latest Developments Table 72. WuXi Biologics Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 73. WuXi Biologics Biological Drug CDMO Product Offered Table 74. WuXi Biologics Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 75. WuXi Biologics Main Business Table 76. WuXi Biologics Latest Developments Table 77. Recipharm Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 78. Recipharm Biological Drug CDMO Product Offered Table 79. Recipharm Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 80. Recipharm Main Business Table 81. Recipharm Latest Developments Table 82. Thermo Fisher Scientific Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 83. Thermo Fisher Scientific Biological Drug CDMO Product Offered Table 84. Thermo Fisher Scientific Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 85. Thermo Fisher Scientific Main Business Table 86. Thermo Fisher Scientific Latest Developments Table 87. AGC Biologics Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 88. AGC Biologics Biological Drug CDMO Product Offered Table 89. AGC Biologics Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 90. AGC Biologics Main Business Table 91. AGC Biologics Latest Developments Table 92. Rentschler Biopharma Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 93. Rentschler Biopharma Biological Drug CDMO Product Offered Table 94. Rentschler Biopharma Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 95. Rentschler Biopharma Main Business Table 96. Rentschler Biopharma Latest Developments Table 97. KBI Biopharma Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 98. KBI Biopharma Biological Drug CDMO Product Offered Table 99. KBI Biopharma Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 100. KBI Biopharma Main Business Table 101. KBI Biopharma Latest Developments Table 102. Siegfried Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 103. Siegfried Biological Drug CDMO Product Offered Table 104. Siegfried Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 105. Siegfried Main Business Table 106. Siegfried Latest Developments Table 107. Aenova Group Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 108. Aenova Group Biological Drug CDMO Product Offered Table 109. Aenova Group Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 110. Aenova Group Main Business Table 111. Aenova Group Latest Developments Table 112. GenScript Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 113. GenScript Biological Drug CDMO Product Offered Table 114. GenScript Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 115. GenScript Main Business Table 116. GenScript Latest Developments Table 117. ProBioGen Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 118. ProBioGen Biological Drug CDMO Product Offered Table 119. ProBioGen Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 120. ProBioGen Main Business Table 121. ProBioGen Latest Developments Table 122. Northway Biotech Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 123. Northway Biotech Biological Drug CDMO Product Offered Table 124. Northway Biotech Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 125. Northway Biotech Main Business Table 126. Northway Biotech Latest Developments Table 127. 3P Biopharmaceuticals Details, Company Type, Biological Drug CDMO Area Served and Its Competitors Table 128. 3P Biopharmaceuticals Biological Drug CDMO Product Offered Table 129. 3P Biopharmaceuticals Biological Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 130. 3P Biopharmaceuticals Main Business Table 131. 3P Biopharmaceuticals Latest Developments List of Figures Figure 1. Biological Drug CDMO Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Biological Drug CDMO Market Size Growth Rate (2020-2031) ($ millions) Figure 6. Biological Drug CDMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 7. Biological Drug CDMO Sales Market Share by Country/Region (2024) Figure 8. Biological Drug CDMO Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 9. Global Biological Drug CDMO Market Size Market Share by Type in 2024 Figure 10. Biological Drug CDMO in SMBs Figure 11. Global Biological Drug CDMO Market: SMBs (2020-2025) & ($ millions) Figure 12. Biological Drug CDMO in Large Companies Figure 13. Global Biological Drug CDMO Market: Large Companies (2020-2025) & ($ millions) Figure 14. Global Biological Drug CDMO Market Size Market Share by Application in 2024 Figure 15. Global Biological Drug CDMO Revenue Market Share by Player in 2024 Figure 16. Global Biological Drug CDMO Market Size Market Share by Region (2020-2025) Figure 17. Americas Biological Drug CDMO Market Size 2020-2025 ($ millions) Figure 18. APAC Biological Drug CDMO Market Size 2020-2025 ($ millions) Figure 19. Europe Biological Drug CDMO Market Size 2020-2025 ($ millions) Figure 20. Middle East & Africa Biological Drug CDMO Market Size 2020-2025 ($ millions) Figure 21. Americas Biological Drug CDMO Value Market Share by Country in 2024 Figure 22. United States Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 23. Canada Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 24. Mexico Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 25. Brazil Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 26. APAC Biological Drug CDMO Market Size Market Share by Region in 2024 Figure 27. APAC Biological Drug CDMO Market Size Market Share by Type (2020-2025) Figure 28. APAC Biological Drug CDMO Market Size Market Share by Application (2020-2025) Figure 29. China Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 30. Japan Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 31. South Korea Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 32. Southeast Asia Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 33. India Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 34. Australia Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 35. Europe Biological Drug CDMO Market Size Market Share by Country in 2024 Figure 36. Europe Biological Drug CDMO Market Size Market Share by Type (2020-2025) Figure 37. Europe Biological Drug CDMO Market Size Market Share by Application (2020-2025) Figure 38. Germany Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 39. France Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 40. UK Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 41. Italy Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 42. Russia Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 43. Middle East & Africa Biological Drug CDMO Market Size Market Share by Region (2020-2025) Figure 44. Middle East & Africa Biological Drug CDMO Market Size Market Share by Type (2020-2025) Figure 45. Middle East & Africa Biological Drug CDMO Market Size Market Share by Application (2020-2025) Figure 46. Egypt Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 47. South Africa Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 48. Israel Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 49. Turkey Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 50. GCC Countries Biological Drug CDMO Market Size Growth 2020-2025 ($ millions) Figure 51. Americas Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 52. APAC Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 53. Europe Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 54. Middle East & Africa Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 55. United States Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 56. Canada Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 57. Mexico Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 58. Brazil Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 59. China Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 60. Japan Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 61. Korea Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 62. Southeast Asia Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 63. India Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 64. Australia Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 65. Germany Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 66. France Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 67. UK Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 68. Italy Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 69. Russia Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 70. Egypt Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 71. South Africa Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 72. Israel Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 73. Turkey Biological Drug CDMO Market Size 2026-2031 ($ millions) Figure 74. Global Biological Drug CDMO Market Size Market Share Forecast by Type (2026-2031) Figure 75. Global Biological Drug CDMO Market Size Market Share Forecast by Application (2026-2031) Figure 76. GCC Countries Biological Drug CDMO Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lonza|||Catalent|||Samsung Biologics|||FUJIFILM Diosynth Biotechnologies|||Boehringer Ingelheim|||WuXi Biologics|||Recipharm|||Thermo Fisher Scientific|||AGC Biologics|||Rentschler Biopharma|||KBI Biopharma|||Siegfried|||Aenova Group|||GenScript|||ProBioGen|||Northway Biotech|||3P Biopharmaceuticals